Chelating Agents for Neurodegenerative Diseases

E-ISSN： 1875-533x|19|17|2760-2772

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.19, Iss.17, 2012-06, pp. : 2760-2772

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Repurposing of Copper(II)-chelating Drugs for the Treatment of Neurodegenerative Diseases

Current Medicinal Chemistry, Vol. 25, Iss. 4, 2018-02 ,pp. : 525-539

Bentham Science Publishers

Access to resources Recommend Favorite

Agents for the treatment of neurodegenerative diseases: July - December 1997

By Baudy R.B.

Expert Opinion on Therapeutic Patents, Vol. 8, Iss. 4, 1998-04 ,pp. : 395-438

Informa Healthcare

Access to resources Recommend Favorite

Agents for the treatment of neurodegenerative diseases: July - December 1996

By Baudy R.B.

Expert Opinion on Therapeutic Patents, Vol. 7, Iss. 5, 1997-05 ,pp. : 471-509

Informa Healthcare

Access to resources Recommend Favorite

Agents for the treatment of neurodegenerative diseases: January - June 1997

By Baudy R.B.

Expert Opinion on Therapeutic Patents, Vol. 7, Iss. 10, 1997-10 ,pp. : 1129-1174

Informa Healthcare

Access to resources Recommend Favorite

Agents for the treatment of neurodegenerative diseases: January - June 1998

By Baudy R.B.

Expert Opinion on Therapeutic Patents, Vol. 8, Iss. 10, 1998-10 ,pp. : 1269-1307

Informa Healthcare

Access to resources Recommend Favorite